Substitute for form 1449/PTO
`
`ALTERNATIVE TO PTO/SB/osA/B
`(Based on PTO 03-08 version)
`
`Complete if Known
`
`1152ko
`september 12,
`New P. own
`1611
`
`Examiner Name
`C. Rae
`
`Attorney Docket Number 638772000109
`
`
`
`
`
`
`
` @NQWPQNT‘
`
`Pages, Columns, Lines, Where
`Name of Patentee or
`Publication Date
`.
`Examiner
`Relevant Passages or Relevant
`
`MM-DD—YYYY Applicant of Cited Document
`Figures Appear
`US-2003/0199425-A1 10-23-2003 Desai et al.
`
`US-2005/0004002—A1 01-06-2005 Desai et al.
`
`US-2006/0083782—A1 04-20-2006 Desai et al.
`
`US-2006/0121119-A1 06-08-2006 Zenoni et al.
`
`US-2006/0257326—A1 11-16-2006 Desai et al.
`US-2006/0263434-A1 11-23-2006 Desai et al.
`US-2007/0020337-A1 01-25-2007 Zenoni et al.
`US-2007/0082838—A1 04-12-2007 De et al.
`59
`US-2007/0087022—A1 04-19-2007 Desai et al.
`_. .0
`US-2007/0092563-A1 04-26-2007 Desai et al.
`
`US-2007/01 16774-A1 05-24-2007 Desai et al.
`_._. NA
`US-2007/0117133-A1 05-24-2007 Trieu et al.
`US-2007/01 17744-A1 05-24-2007 Desai et al.
`
`US-2007/01 17862-A1 05-24-2007 Desai et al.
`
`US-2007/01 17863-A1 05-24-2007 Desai et al.
`
`US-2007/0128290-A1 06-07-2007 Desai et al.
`
`US-2007/0129448—A1 06-07-2007 Desai et al.
`US-2007/01 66388-A1 07-19-2007 Desai et al.
`
`US-2007/0196361-A1 08-23-2007 Soon-Shiong et al.
`US-4,534,899
`08-13-1985 Sears
`
`US-5,059,699
`10-22-1991 Kingston et al.
`
`US-5,362,478—A
`11-08-1994 Desai et al.
`
`US-5,362,831-A
`11-08-1994 Mongelli
`US-5,399,363-A
`03-21-1995 Liverside et al.
`US-5,415,869-A
`05-16-1995 Straubiner et al.
`
`US-5,424,073-A
`06-13-1995 Rahman et al.
`US-5,439,686—A
`08-08-1995 Desai et al.
`
`US-5,498,421-A
`03-12-1996 Grinstaff et al.
`US-5,505,932—A
`04-09-1996 Grinstaff et al.
`
`US-5,508,021-A
`04-16-1996 Grinstaff et al.
`US-5,512,268—A
`04-30-1996 Grinstaff et al.
`US-5,560,933-A
`10-01-1996 Soon-Shion et al.
`
`US-5,565,478—A
`10-15-1996 Kohn et al.
`
`US-5,567,434-A
`10-22-1996 Szoka, Jr.
`
`US-5,616,608—A
`04-01-1997 Kinsella et al.
`US-5,626,862—A
`05-06-1997 Brem et al.
`
`US-5,626,867-A
`05-06-1997 Eibl et al.
`US-5,635,207-A
`06-03-1997 Grinstaff et al.
`US-5,639,473-A
`06-17-1997 Grinstaff et al.
`
`US-5,648,090-A
`07-15-1997 Rahman et al.
`
`US-5,650,156—A
`07-22-1997 Grinstaff et al.
`
`US-5,651,986—A
`07-29-1997 Brem et al.
`US-5,665,382—A
`09-09-1997 Grinstaff et al.
`
`US-5,665,383-A
`09-09-1997 Grinstaff et al.
`US-5,670,536—A
`09-23-1997 Durr et al.
`.
`US-5,683,715-A
`11-04-1997 Boni et al.
`46.
`
`47.
`US-5,703,117-A
`12-30-1997 Mayhew et al.
`A raxis EX2004
`
`Actavis LLC v. Abraxis Bioscience, LLC
`|PR2017-O11OO
`paflifi‘lfiEFERENCES CQNSlDERED EXCEPT WHERE LlNED THRQUGH.
`/CR/
`
`

`

`Substitute for form 1449/PTO
`
`ALTERNATIVE TO PTO/SB/osA/B
`(Based on PTO 03-08 version)
`
`Complete if Known
`
`11/520,479
`september 12,
`New P. own
`1611
`
`Examiner Name
`C. Rae
`
`Attorney Docket Number 638772000109
`
`
`
`
`
`
`
`02-10-1998 Hunter et al.
`US-5,716,981-A
`
`US-5,731,334-A
`03-24-1998 Wrasidlo
`
`US-5,733,925-A
`03-31-1998 Kunz et al.
`
`US-5,756,537-A
`05-26-1998 Gill
`US-5,766,635-A
`06-16-1998 Senleuhauer et al.
`
`US-5,795,909-A
`09-22-1998 Shashoua et al.
`US-5,811,447-A
`09-22-1998 Kunz et al.
`US-5,886,026—A
`03-23-1999 Hunter et al.
`
`US-5,916,596—A
`06-29-1999 Desai et al.
`
`US-5,928,669-A
`07-27-1999 Davis et al.
`
`US-5,945,033-A
`08-31-1999 Yen
`US-5,977,163-A
`11-02-1999 Li et al.
`
`US-5,981,568-A
`11-09-1999 Kunz et al.
`US-5,994,341-A
`11-30-1999 Hunter et al.
`
`US-5,997,904-A
`12-07-1999 Magdassi et al.
`
`US-6,051,600-A
`04-18-2000 Mayhew et al.
`
`US-6,066,668-A
`05-23-2000 Hausheer et al.
`
`US-6,074,659-A
`06-13-2000 Kunz et al.
`US-6,096,331-A
`08-01-2000 Desai et al.
`
`US-6,107,332—A
`08-22-2000 Ali et al.
`US-6,120,805-A
`09-19-2000 Senlehauer et al.
`
`US-6,143,276—A
`11-07-2000
`
`US-6,146,659-A
`11-14-2000
`
`US-6,179,817-B1
`01-30-2001
`US-6,197,051-B1
`03-06-2001
`US-6,197,349-B1
`03-06-2001 Westesen et al.
`
`US-6,268,390-B1
`07-31-2001 Kunz
`US-6,306,421-B1
`10-23-2001 Kunz et al.
`
`US-6,322,805-B1
`11-27-2001 Kim et al.
`
`US-6,441,025-B2
`08-27-2002 Li et al.
`
`US-6,458,373-B1
`09-24-2002 Lambert et al.
`US-6,500,461 B2
`12-31-2002 Perkins et al.
`US-6,506,405-B1
`01-14-2003 Desai et al.
`
`US-6,528,067-B1
`03-04-2003 Magdassi et al.
`US-6,537,579-B1
`03-25-2003 Desai et al.
`
`US-6,565,842—B1
`05-20-2003 Sojomihardjo et al.
`US-6,652,884-B2
`11-25-2003 Falciani
`US-6,743,826—B1
`06-01-2004 Hegedus et al.
`US-6,749,868-B1
`06-15-2004 Desai et al.
`US-6,753,006-B1
`06-22-2004 Desai et al.
`.
`
`88.
`US-6,759,431-B2
`07-06-2004 Hunter et al.
`89.
`US-7,238,369-B2
`07-03-2007 McDonald et al.
`
`90.
`US-7,332,568-B2
`02-19-2008 Trieu etal.
`
`pafli‘ié‘ifiEFERENCES CONSiQERED EXCEPT WHERE LiNEE} THRQUGH.
`
`/CR/
`
`

`

`Substitute for form 1449/PTO
`
`ALTERNATIVE TO PTO/SB/osA/B
`(Based on PTO 03-08 version)
`
`Complete if Known
`
`11/520,479
`september 12,
`Nei P. oEsm
`
`Examiner Name
`
`C. Rae
`
`Attorney Docket Number 638772000109
`
`
`
`
`
`
`
`
`FOREIGN PATENT DOCUMENTS
`
`of
`or
`
`lnitials"
`N0.l
`Country Codes-NumberA-Kind Code5 (ifknown) MM.DD.YYYY
`Applicant 0f C'ted Document
`Or Relevant Figures Appear T6
`.
`Translation of
`
`91.
`CN-1148957-A
`05-07-1997 Zhang Hairu
`Abstract only
`92. WO-93/24476—A1
`12-09-1993 Clover Consolidated Limited
`:|
`
`93. WO-94/18954-A1
`09-01-1994 Clover Consolidated Limited
`_|
`
`94. WO-95/03036—A1
`02-02-1995 mg'ogenes's Te°hnol°9'es’
`
`95. WO-96/02247-A1
`02-01-1996 Hemagen PFC
`96. WO-96/40091-A1
`12-19-1996 VivoRx Pharmaceuticals, Inc.
`97. WO-96/40829-A1
`12-19-1996 VivoRx Pharmaceuticals, Inc.
`98. WO-97/10849-A1
`03-27-1997 Sam Yan Co., Ltd.
`99. WO-98/14174-A1, C1
`04-09-1998 VivoRx Pharmaceuticals, Inc.
`100. WO-99/13914-A1
`03-25-1999 Human Rt.
`
`:I
`
`Examiner
`Si nature
`
`Date
`Considered
`
`*EXAMINER: Initial if information considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`considered.
`Include copy of this form with next communication to applicant.
`‘Applicant's unique citation designation number (optional). 2See Kinds Codes of
`USPTO Patent Documents at www.uspto.gov or MPEP 901.04.
`5 Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3).
`A For
`Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document. 5 Kind of document by
`the appropriate symbols as indicated on the document under WIPO Standard ST. 16 if possible. 6Applicant is to place a check mark here if English language
`Translation is attached.
`
`NON PATENT LITERATURE DOCUMENTS
`
`Exammer
`lnmals
`
`T2
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of
`the item (book, magazine, journal, serial, symposium, catalog, etc), date, page(s), volume-issue
`one
`number s , ublisher, cit and/or countr where ublished.
`No'l
`BARTOLI, M.H. et aI. (April-June 1990). “In Vitro and In Vivo Antitumoral Activity of Free, and D
`101
`102
`DESAI, N.P. et aI. (April 1994). "Controlled and Targeted Drug Delivery With Biocompatible
`'
`Protein Shell Microspheres," The 20th Annual Meeting of the Society for Biomaterials, Boston,
`
`MA, April 5-9, 1994, one page.
`
`
`
`
`'
`
`Enca sulated Taxol,” Journal of Microenca sulation 7 2 :191-197.
`
`103-
`
`
`
`DESAI, N.P. et aI. (October - November 1994). "Intravenous Targeted Delivery of Chemo-
`therapeutic Agents in Protein Microspheres," XIV International Cancer Progress, New Delhi,
`India, October 30 - November 5, 1994, one page.
`
`DESAI, N.P. et aI. (March 1995). “In Vivo Drug Delivery With Biocompatible Protein Shell
`104-
`Microspheres," The 215’ Annual Meeting of the Society for Biomaterials, San Francisco, CA,
`
`March 18-22, 1995, one page.
`DESAI, N.P. et aI. (August 1995). "Protein Microcapsules as Drug Delivery Vehicles," 26th
`105.
`
`Annual Meeting of the Fine Particle Society, Chicago, IL, August 22-25, 1995, one page.
`DESAI, N.P. et aI. (April - May 1997). “Protein-Stabilized Nanoparticles as Drug Delivery
`Vehicles,” Transactions: 23’d Annual Meeting of the Society for Biomaterials, New Orleans, LA,
`April 30 - May 4, 1997, 20:172.
`DESAI, N.P. et aI. (April 1998). "Protein Based Nanoparticle Delivery Systems," 28th Annual
`Meeting of the Fine Particle Society, Dallas, TX, April 1-3, 1998, one page.
`
`107.
`
`106.
`
`pafltfflé‘lngFERENCES CONSiDERED EXCEPT WHERE LiNED THROUGH.
`
`iCR/
`
`

`

`Substitute for form 1449/PTO
`
`ALTERNATIVE TO PTO/SB/osA/B
`(Based on PTO 03-08 version)
`
`Complete if Known
`
`
`
`1152ko
`september 12.
`New P. own
`1611
`Examiner Name
`C. Rae
`
`Attorney Docket Number 638772000109
`
`108.
`
`D 1
`
`
`
`DOSIO, F. et al. (1997). “Preparation, Characterization and Properties In Vitro and In Vivo of a
`Paclitaxel-Albumin Con'u ate,” J. Cont. Rel. 47:293-204.
`GRINSTAFF, M.W. et al. (March 1994). “Intravenous Targeted Delivery of Taxol in Protein
`109. Microspheres,” Abstracts of Papers 207”’ National Meeting of the American Chemical Society,
`1994, San Diego, CA, March 13-17, 1994, 207(1-2), Abstract No. 91, one page.
`LEYLAND-JONES, B.
`(February 1993). “Targeted Drug Delivery,” Seminars in Oncology
`10.
`
`20(1):12-17.
`MATHEW, A.E. et al. (1992). “Synthesis and Evaluation of Some Water-Soluble Prodrugs and
`111.
`Derivatives of Taxol with Antitumor Activit
`J. Med. Chem. 35 1
`:145-151.
`MERISKO-LIVERSIDGE, E. (1996). “Formulation and Antitumor Activity Evaluation of
`Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs,” Pharmaceutical Research
`13 2 :272-278.
`
` attached.)
`
`DEED
`120.
`
`1 12.
`
`113'
`
`114-
`
`RIONDEL, J. et al. (January - February 1992). “Effects of Free and Liposome-Encapsulated
`Taxol on Two Brain Tumors Xeno rafted into Nude Mice,” In Vivo 6 1
`:23-27.
`
`Non-Final Office Action mailed on June 22, 2007, for US. Application No. 11/544,737, filed on
`October 5, 2006, 9 a es.
`
`
`115-
`Non-Final Office Action mailed on June 22, 2007, for US. Application No. 11/544,794, filed on
`October 5, 2006, 9 pages.
`Non-Final Office Action mailed on June 14, 2007, for US. Application No. 11/544,523, filed on
`116.
`October 5, 2006, 8 pages.
`Non-Final Office Action mailed on June 22, 2007, for US. Application No. 11/544,781, filed on
`117.
`October 5, 2006, 9 pages.
`Non-Final Office Action mailed on June 22, 2007, for US. Application No. 11/635,253, filed on
`December 5, 2006, 9 pages.
`
`118.
`
`
`
`Non-Final Office Action mailed on June 22, 2007, for US. Application No. 11/635,252, filed on
`119.
`
`December 5, 2006, 9 pages.
`
`US. Patent Application No. 09/446,783, filed on May 16, 2000, for Desai et al. (Copy not
`
`121. US. Patent Application No. 09/937,840, filed on January 28, 2002, for Desai et al. (Copy not
`attached.)
`
`
`122
`US. Patent Application No. 11/553,339, filed on October 26, 2006, for Desai et al. (Copy not
`'
`attached.)
`
`123. US. Patent Application No. 11/833,179, filed on August 2, 2007, for Desai et al. (Copy not
`attached.)
`
`124. US. Patent Application No. 11/833,188, filed on August 2, 2007, for Desai et al. (Copy not
`attached.)
`
`125. US. Patent Application No. 11/880,218, filed on July 19, 2007, for Desai et al. (Copy not
`attached.)
`
`126. US. Patent Application No. 11/880,314, filed on July 20, 2007, for Desai et al.
`attached.)
`
`(Copy not
`
`
`
`
`127. US. Patent Application No. 11/890,006, filed on August 3, 2007, for Desai et al.
`attached.)
`
`128. US. Patent Application No. 11/890,041, filed on August 3, 2007, for Desai et al.
`attached.)
`
`(Copy not
`
`(Copy not
`
`(Copy not
`129. US. Patent Application No. 11/890,197, filed on August 3, 2007, for Desai et al.
`attached.)
`
`paAE1§4F§EFERENCES CONSiDERED EXCEPT WHERE LiNED THROUGH.
`
`iCR/
`
`

`

`Substitute for form 1449/PTO
`
`ALTERNATIVE TO PTO/SB/osA/B
`(Based on PTO 03-08 version)
`
`Complete if Known
`
`“520.479
`september 12.
`New P. own
`1611
`Examiner Name
`C. Rae
`
`Attorney Docket Number 638772000109
`
`130.
`
`U.S. Patent Application No. 11/890,599, filed on August 6, 2007, for Desai et al.
`attached.)
`
`(Copy not
`
`131.
`U.S. Patent Application No. 11/890,603, filed on August 6, 2007, for Desai et al. (Copy not
`
`attached.)
`
`
`
`132.
`
`U.S. Patent Application No. 11/890,639, filed on August 6, 2007, for Desai et al.
`attached.)
`
`(Copy not
`
`133.
`U.S. Patent Application No. 11/890,648, filed on August 6, 2007, for Desai et al.
`(Copy not
`
`attached.)
`
`134.
`
`U.S. Patent Application No. 11/890,819, filed on August 7, 2007, for Desai et al.
`attached.)
`
`(Copy not
`
`135.
`U.S. Patent Application No. 11/897,724, filed on August 31, 2007, for Desai et al.
`(Copy not
`
`attached.)
`
`
`
`
`
`
`
`136.
`
`U.S. Patent Application No. 12/051 ,782, filed on March 19, 2008, for Desai et al.
`attached.)
`
`(Copy not
`
`137
`
`'
`
`American BioScience, Inc. V. Baker Norton Pharmaceuticals, Inc. et al., Case No. CV 00-
`09589 (MRP), before United States District Court for the Central District of California, 2002
`U.S. Dist. Lexis 512, January 10, 2002, four pages.
`
`Signature
`
`Considered
`08/14/2008
`/Chariesw0rth Rae/
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`considered.
`Include copy of this form with next communication to applicant.
`
`‘Applicant's unique citation designation number (optional). 2Applicant is to place a check mark here if English language Translation is attached.
`
`pafli‘ié‘ingFERENCES CONSiDERED EXCEPT WHERE LiNED THRQUGH.
`
`/CR/
`
`